• A Study of Orforglipron for Knee Pain Relief in Adults with Obesity or Overweight and Knee Osteoarthritis

    Recruiting

    3 1
    Investigated diseases:
    Germany Spain
  • Study of ubamatamab alone or with cemiplimab for adults with ovarian, fallopian tube, peritoneal, or endometrial cancer that has come back

    Recruiting

    2 1 1 1
    Belgium France Italy The Netherlands Spain
  • Study comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor

    Recruiting

    3 1 1 1
    Investigated diseases:
    Germany Greece Hungary Poland Romania Spain
  • A study on the long-term effectiveness and safety of nine-valent human papillomavirus vaccine in women aged 16 to 26 years for prevention of cervical cancer

    Recruiting

    3 1 1 1
    Denmark Norway Sweden
  • Study of oral cladribine compared to placebo for patients with generalized myasthenia gravis

    Recruiting

    3 1 1
    Investigated diseases:
    Belgium Bulgaria Czechia France Germany Greece +6
  • Testing MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment

    Recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Greece +7
  • A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Finland France Germany Italy Poland +2
  • A Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

    Recruiting

    2 1 1 1
    Belgium France Ireland Italy Poland Spain
  • A study testing how well patiromer lowers high potassium levels in the blood in children under 12 years of age with hyperkalemia

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Finland France Greece Hungary Italy +5
  • Study comparing datopotamab deruxtecan with or without durvalumab to chemotherapy with pembrolizumab for patients with triple-negative breast cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    France Italy Poland Spain

powered by